---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-015785"
form_type: "8-K"
ticker: "KALA"
cik: "0001479419"
company_name: "KALA BIO, Inc."
filed_at: "2022-11-01T23:59:59+00:00"
generated_at: "2026-06-22T17:58:59.898476+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Kala Pharmaceuticals appoints Marjan Farid, M.D. to board of directors

## Summary
- Dr. Farid appointed as Class I director effective Oct. 31, 2022; term expires at 2024 annual meeting.
- She joins the Nominating and Corporate Governance Committee.
- Received a one-time stock option to purchase 1,600 shares at $6.35 per share (closing price on appointment date).
- Option vests 1/3 on first anniversary, then monthly over three years; standard indemnification agreement.

## SEC filing metadata
- accession: 0001558370-22-015785
- form_type: 8-K
- ticker: KALA
- cik: 0001479419
- company_name: KALA BIO, Inc.
- filed_at: 2022-11-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479419/000155837022015785/0001558370-22-015785-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479419/000155837022015785/kala-20221031x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-015785
- JSON: https://secwatch.observer/filing/0001558370-22-015785.json
- Plain text: https://secwatch.observer/filing/0001558370-22-015785.txt

## Key facts
- Executive change
  Marjan Farid, M.D. was appointed as Class I director at KALA BIO, Inc..
  - Action: appointed
  - Role: Class I director
  source text: On October 31,, 2022, upon the recommendation of the Nominating and Corporate Governance Committee of Kala Pharmaceuticals, Inc. (the “Company”), the Board of Directors of the Company (the “Board”) appointed Marjan Farid, M.D. as a member of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000155837022015785/0001558370-22-015785-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.